Elizabeth Richter

Title: Elizabeth Richter: Innovator in Plant-Based Immunogenic Solutions

Introduction

Elizabeth Richter is a prominent inventor based in Ithaca, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of plant expression vectors for immunogenic polypeptides. Her work aims to harness the potential of transgenic plants to produce important medical compounds.

Latest Patents

Elizabeth Richter holds a patent for the "Expression of immunogenic hepatitis B surface antigens in transgenic plants." This innovative patent describes plant expression vectors that comprise at least two expression cassettes, which function to reduce transcriptional silencing of polynucleotide expression. The vectors are designed to produce immunogenic polypeptides, including HBsAg, in edible plant tissues. These edible tissues can elicit an immune response in humans and animals when consumed, showcasing a novel approach to vaccine delivery.

Career Highlights

Richter is affiliated with the Boyce Thompson Institute for Plant Research, where she conducts her research. Her work has positioned her as a leader in the field of plant biotechnology, focusing on the intersection of agriculture and medicine.

Collaborations

Some of her notable coworkers include Hugh S. Mason and Yasmin M. Thanavala, who have also contributed to advancements in plant-based immunology.

Conclusion

Elizabeth Richter's innovative work in the field of plant biotechnology exemplifies the potential of transgenic plants in medical applications. Her contributions are paving the way for new methods of vaccine production and delivery.